Pharma fears “lack of focus” on no-deal Brexit preparations

22 March 2019 - As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages. ...

Read more →

NICE nod for Takeda’s Adcetris in advanced stage CTCL

22 March 2019 - Takeda has announced the NICE recommendation of its advanced cutaneous T-cell lymphoma drug Adcetris (brentuximab vedotin). ...

Read more →

NICE terminates yet another assessment of a cancer medicine

20 March 2019 - This time it is pembrolizumab (Keytruda). ...

Read more →

Is Orkambi deal close? Vertex meets again today with NHS England

21 March 2019 - Campaigners hopes rise after three year wait. ...

Read more →

York man Paul Thomas-Peter says he could die because NHS won't fund drug

19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...

Read more →

Unprecedented drug shortage linked to Brexit, NHS bosses say

20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...

Read more →

The shadow of Brexit on speed of access

20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union.  ...

Read more →

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

18 March 2019 - Suggests Orkambi row has undermined confidence in NICE process. ...

Read more →

CMA drops anti-competitive case against MSD

18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...

Read more →

NICE celebrates its 20th anniversary

18 March 2019 - Organisation was founded in April 1999 to improve outcome for health service users ...

Read more →

One in four cancer patients wait two months for treatment, as NHS performance hits record low

14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...

Read more →

An EU wide approach to HTA: an irrelevant development or an opportunity not to be missed?

14 March 2019 - An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness ...

Read more →

UK breast cancer patients win early access to Tecentriq/nab-paclitaxel

14 March 2019 - Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer have ...

Read more →

Cancer patient denied life-prolonging drug as she lives half a mile outside England

13 March 2019 - A seriously ill mum-of-two has spoken of her devastation after being denied a life prolonging cancer drug ...

Read more →

Pharma urges politicians to stop no-deal Brexit in today’s vote

13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...

Read more →